
About Keimed
Keimed is a Healthcare company based in Hyderabad (India) founded in 2000. Temperature-sensitive medicines are distributed via cold chain logistics by Keimed. Keimed has raised $16.62 million across 2 funding rounds from investors including Mitsui & Co and Apollo Hospitals. The company has 588 employees. Keimed was last valued at $122.86 million in August 2015. Its chief executive, as recorded, is Gaurav Chaturvedi. Its Indian entity Keimed Private Limited reported revenue of ₹1,265 Cr. Keimed offers products and services including Medicine Distribution Service and Cold Chain Logistics. Its focus areas include Pharmaceutical Distributors and Diversified. Its competitors include Entero Healthcare, Sandor Medicaids and Mahaveer Medi Sales; 2 of its 3 listed competitors have raised funding.
Company details
Founded in 2000 in Hyderabad, India, Keimed operates in the pharmaceutical distribution sector. Temperature-sensitive medicines are sourced directly from manufacturers and stored in specialized facilities to preserve quality and effectiveness. A rapid logistics system is employed for timely deliveries, supported by advanced cold chain infrastructure and technology. Operations focus on efficiency across the supply chain in the Indian market.
- Headquarters Hyderabad, India
- Employees 588
- Stage Minicorn
- SectorsHealthcare
- Website keimed.com
- Social LinkedIn
- Legal Name Keimed Private Limited
- Date of Incorporation 10 Mar, 2000
- Jurisdiction Chennai, Tamil Nadu, India
- Annual Revenue₹1,265 Cr
FY 2026 · +13% YoY
- Net Profit₹241 Cr
FY 2026 · 2% margin
- EBITDA₹459 Cr
FY 2026 · 3% margin
- Total Equity Funding$16.62M (USD)
in 2 rounds
- Latest Funding Round$11.7M (USD), Series B
Mar 2025
- InvestorsMitsui & Co.
& 1 more
- Employee Count588
Associated legal entities of Keimed
Keimed is associated with 2 registered companies on The Company Check; the primary company is Keimed Private Limited. Each company page carries the filings, financials, charges and directors of that entity.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2026) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Keimed Private Limited CIN U72200TN2000PTC179280 | Active | 10 Mar 2000 | Chennai, Tamil Nadu | ₹1,265 Cr | 420 | 8 | View details |
| Kamineni Enterprises International Llp CIN ABC-9374 | Active | 07 Nov 2022 | Hyderabad, Telangana | 5 | View details |
Products & Services of Keimed
Keimed offers a comprehensive portfolio of products and services, including Medicine Distribution Service and Cold Chain Logistics.
Provides nationwide delivery of genuine, temperature-controlled medicines.
Ensures integrity of temperature-sensitive healthcare products during transport.
Funding Insights of Keimed
Keimed has successfully raised a total of $16.62M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $11.7 million completed in March 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $16.62M
- Total Rounds 2
- Last Round Series B — $11.7M
- First Round $4.92M
(Aug 2015)
- Investors Count 2
All 2 funding rounds of Keimed with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2025 | $11.7M | Series B | – | Apollo Hospitals | – |
| Aug 2015 | $4.92M | Series A | $122.86M | Mitsui | – |
| Date | Valuation | Stage |
|---|---|---|
| Aug 2015 | $122.86M | •••••••• |
Last known valuation $122.86M (Aug 2015). 2 investors in total: 2 institutional.
Investors in Keimed
Keimed has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Mitsui & Co and Apollo Hospitals.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Traditional conglomerate services are provided across multiple sectors by Mitsui. | 1947 | mitsui.com | Chiyoda City, Japan | |
Chain of multispecialty hospitals | 1983 | apollohospitals.com | Chennai, India |
Investor details for Keimed
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Keimed Private Limited (Keimed)
Keimed Private Limited is the primary company behind Keimed. The boards of the 2 registered companies of Keimed currently have 8 directors; the longest-serving is Arvind Kumar Venkat, appointed in 2015. 15 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Arvind Kumar Venkat DIN 02304618 | Managing Director | 31 Jan 2015 | 11 yrs 9 mo | Keimed Private Limited |
| Anil Kamineni DIN 01562283 | Designated Partner | 07 Nov 2022 | 4 yrs | Kamineni Enterprises International Llp |
| Raj Shankar DIN 00238790 | Director | 19 Apr 2023 | 3 yrs 7 mo | Keimed Private Limited |
| Pankaj Patwari DIN 08206620 | Director | 03 Oct 2024 | 2 yrs 1 mo | Keimed Private Limited |
| Shobana Kamineni DIN 00003836 | Partner | 30 Dec 2024 | 1 yr 10 mo | Kamineni Enterprises International Llp, Keimed Private Limited |
| Anuspala Kamineni DIN 07486388 | Partner | 30 Dec 2024 | 1 yr 10 mo | Kamineni Enterprises International Llp |
| Upasana Konidela DIN 02781278 | Designated Partner | 30 Dec 2024 | 1 yr 10 mo | Kamineni Enterprises International Llp |
| Puansh Kamineni DIN 08117626 | Partner | 30 Dec 2024 | 1 yr 10 mo | Kamineni Enterprises International Llp, Keimed Private Limited |
People of Keimed
8 people are tracked at Keimed (6 in leadership, 2 in team); the tracked headcount is 588.
| Name | Role | Group |
|---|---|---|
Gaurav Chaturvedi | CEO | Leadership |
| Managing Director | Leadership | |
Alok Polawar | Head - Commercial | Leadership |
Susmit Panja | Chief Technology Officer | Leadership |
Rajeev Bahuguna | Head - Sales | Leadership |
Narasaiah Arigela | Chief Financial Officer | Leadership |
Jagadeesh Vaddi | Gm, Operations | Team |
Swati Shradha | Senior Executive Human Resources ( Apollo Group) | Team |
Complete people profiles for Keimed
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Keimed
Figures of Keimed Private Limited, the primary company behind Keimed, for FY 2026. Revenue was ₹1,265 Cr (+13% year on year). Net profit was ₹241 Cr (2% margin). EBITDA was ₹459 Cr (3% margin). Revenue has grown at a compounded annual rate of +16% over three years and +20% over five years.
- ₹1,265 CrRevenue · FY 2026 · +13% YoY
- ₹241 CrNet profit · 2% margin
- ₹459 CrEBITDA · 3% margin
- ₹6.87 CrPaid-up capital
- 420Employees (provident fund records)
- +16%Revenue CAGR, 3 years
- +20%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Keimed Private Limited are on its company page.
Detailed financial statements for Keimed
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Keimed
4 dated milestones of Keimed across 25 years, from founding to its latest funding, stage changes and deals.
- Founded Keimed is founded.
- Funding First funding round of $4.9M.
- Milestone Reaches Minicorn status.
- Funding Latest funding round, Series B, of $11.7M.
Competitors of Keimed
Keimed has 3 listed competitors in our database, 2 of them funded. They include Entero Healthcare, Sandor Medicaids and Mahaveer Medi Sales.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| enterohealthcare.com | 2018 | Mumbai, India | $59.67M | 817 | India's leading healthcare products distribution platform | |
| sandor.co.in | 1995 | Hyderabad, India | $8.98M | 161 | Provider of medical equipment, devices, and drugs distribution services | |
| mahaveermedi.com | 2016 | Bengaluru, India | 588 | Serves as a distributor of a wide range of pharmaceutical drugs. |
Detailed competitors of Keimed
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Keimed
Complete news archive for Keimed
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Keimed
Keimed was founded in 2000 and raised its 1st funding round 15 years after it was founded.
Keimed is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Gaurav Chaturvedi is the CEO of Keimed, as recorded in our data.
Keimed is a funded company, having raised a total of $16.62M across 2 funding rounds to date. The company's 1st funding round was a Series A of $4.92M, raised on Aug 2015.
Keimed has 588 employees.
The primary company behind Keimed, Keimed Private Limited, reported revenue of ₹1,265 Cr for FY 2026, up 13% year on year.
Founded in 2000 in Hyderabad, India, Keimed operates in the pharmaceutical distribution sector. Temperature-sensitive medicines are sourced directly from manufacturers and stored in specialized facilities to preserve quality and effectiveness. A rapid logistics system is employed for timely deliveries, supported by advanced cold chain infrastructure and technology. Operations focus on efficiency across the supply chain in the Indian market.
Keimed's top competitors include Entero Healthcare, Sandor Medicaids and Mahaveer Medi Sales.
Keimed offers Medicine Distribution Service and Cold Chain Logistics.
Keimed has 2 investors. Key investors include Mitsui & Co, and Apollo Hospitals.
The valuation of Keimed is $122.86M as of Aug 2015.
Keimed is associated with 2 legal entities: Keimed Private Limited, Kamineni Enterprises International Llp.
